An old drug with new tricks
- Details
- Category: Research
New anti-cancer agent works without oxygen
- Details
- Category: Research
GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
- Details
- Category: GlaxoSmithKline
Researchers discovered a cancer mechanism that can eliminate tumors - even those resistant to immunotherapy
- Details
- Category: Research
Implantable microparticles can deliver two cancer therapies at once
- Details
- Category: Research
In hopes of expanding the treatment options for those patients, MIT researchers have designed tiny particles that can be implanted at a tumor site, where they deliver two types of therapy: heat and chemotherapy.
Unique multidomain enzymes from bacteria
- Details
- Category: Research
Natural products produced by living organisms such as plants, animals, and microorganisms, govern various survival and defence purposes. However, these compounds can be repurposed as drugs and medicines. Many well-known drugs, including ibuprofen and penicillin, are derived from these natural products.
Immune cell discovery offers new potential for cancer immunotherapy
- Details
- Category: Research
Bayer and Dewpoint Therapeutics sign licensing agreement for heart disease program
- Details
- Category: Bayer
Repurposing mifepristone: new hope for anti-aging treatments
- Details
- Category: Research
Mifepristone, which is also used to treat Cushing's disease and certain cancers, has caught the attention of scientists exploring ways to promote longer, healthier lives.
U.S. FDA approves Pfizer's RSV vaccine ABRYSVO® for adults aged 18 to 59 at increased risk for disease
- Details
- Category: Pfizer